PB1925: NAOS STUDY: FIRST INTERIM ANALYSIS OF ACALABRUTINIB USE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN A REAL-LIFE SETTING.

• Anne Quinquenel,
• Marie Sarah Dilhuydy,
• Loïc Ysebaert,
• Stephane Lepretre,
• Christine Boileau,
• Gaëlle Cordonnier,
• Hassiba Ould Lahsen,
• Vincent Levy

Affiliations

Anne Quinquenel

1 Hôpital Robert Debré, Reims, France

Marie Sarah Dilhuydy

2 Hôpital Haut-Lévèque, Bordeaux, France

Loïc Ysebaert

3 IUCT - Oncopôle, Toulouse, France

Stephane Lepretre

4 Centre Henri-Becquerel, Rouen, France

Christine Boileau

5 AstraZeneca, Courbevoie, France

Gaëlle Cordonnier

6 AstraZeneca, Courbevoie, France

Hassiba Ould Lahsen

7 AstraZeneca, Paris, France

Vincent Levy

8 Hôpital Avicenne, Bobigny, France